Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07518329
What this trial is testing

Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

Who this might be right for
Non Hodgkin Lymphoma (NHL)Leukaemia
Arovella Therapeutics Ltd 46
Early research (Phase 1)UnknownNCT05346198
What this trial is testing

Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Simnova Biotechnology Co.,Ltd. 15
Not applicableNot Yet RecruitingNCT07740317
What this trial is testing

Neurocognitive Trajectories After BCMA CAR-T

Who this might be right for
Multiple Myeloma (MM)CART TherapyRefractory Multiple Myeloma (RRMM)
Wake Forest University Health Sciences 50
Not applicableStudy completedNCT05784415
What this trial is testing

Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell

Who this might be right for
LeukemiaLeukemia, LymphoblasticLymphoma, Large B-Cell, Diffuse+7 more
AIDS Malignancy Consortium 30
Testing effectiveness (Phase 2)UnknownNCT01869166
What this trial is testing

Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)

Who this might be right for
Advanced EGFR-positive Solid Tumors
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05850286
What this trial is testing

VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)UnknownNCT04163302
What this trial is testing

Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02471430
What this trial is testing

Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV Infection
Massachusetts General Hospital 17
Testing effectiveness (Phase 2)Looking for participantsNCT07106723
What this trial is testing

Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL

Who this might be right for
CD7 PositiveT - Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)Looking for participantsNCT07178431
What this trial is testing

MB-CART2019.1 in Refractory Multiple Sclerosis

Who this might be right for
Multiple SclerosisCAR T Cell Therapy
Miltenyi Biomedicine GmbH 26
Early research (Phase 1)Not Yet RecruitingNCT06633042
What this trial is testing

The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD

Who this might be right for
Autoimmune Disease
Bioray Laboratories 18
Testing effectiveness (Phase 2)UnknownNCT04162119
What this trial is testing

Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Chinese PLA General Hospital 30
Early research (Phase 1)Ended earlyNCT03994705
What this trial is testing

Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cartesian Therapeutics 20
Early research (Phase 1)UnknownNCT03599375
What this trial is testing

Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, B-Cell
jiuwei cui 20
Testing effectiveness (Phase 2)Looking for participantsNCT06267729
What this trial is testing

Study of AZD0754 in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 60
Early research (Phase 1)UnknownNCT02822326
What this trial is testing

Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia

Who this might be right for
Acute Leukemia
Guangdong Provincial People's Hospital 30
Early research (Phase 1)Ended earlyNCT06304636
What this trial is testing

Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaRelapsed Multiple Myeloma
Cartesian Therapeutics 4
Not applicableUnknownNCT04780529
What this trial is testing

CART Therapy in Digestive System Tumors

Who this might be right for
Malignant Neoplasms of Digestive Organs
Innovative Cellular Therapeutics Co., Ltd. 20
Early research (Phase 1)Looking for participantsNCT07333430
What this trial is testing

Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (MM)
Hadassah Medical Organization 60
Early research (Phase 1)Active Not RecruitingNCT06768476
What this trial is testing

CART123 + Ruxolitinib in Relapsed/Refractory AML

Who this might be right for
Relapsed AMLRefractory AML
University of Pennsylvania 12
Next Page